Cancer attrition immunotherapy
Crossref DOI link: https://doi.org/10.30574/wjarr.2021.12.2.0649
Published Online: 2021-11-30
Update policy: https://doi.org/10.30574/wjarr.ourcrossmarkpolicy
Michael John Dochniak,
